Ralph D'Agostino to Mutation
This is a "connection" page, showing publications Ralph D'Agostino has written about Mutation.
Connection Strength
0.429
-
Smith MR, Wang Y, Dixon CB, D'Agostino R, Liu Y, Ruiz J, Oliver G, Miller LD, Topaloglu U, Chan MD, Farris M, Su J, Mileham KF, Li W, Grayson JM, Lycan T, Xing F. Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies. Clin Lung Cancer. 2024 Dec; 25(8):e379-e388.
Score: 0.183
-
Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED, D'Agostino RB, Petro RM, Blackstock W, Powell BL, Abraham E, Pasche B, Zhang W. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. J Hematol Oncol. 2017 05 04; 10(1):100.
Score: 0.111
-
Smith MR, Dixon CB, Wang Y, Liu Y, D'Agostino R, Ruiz J, Oliver G, Miller LD, Topaloglu U, Chan MD, Farris M, Su J, Mileham KF, Zhao D, Li W, Sexton T, Lycan T, Haas KM, Grayson JM, Xing F. Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer. Cancer Res. 2024 Dec 02; 84(23):4002-4016.
Score: 0.047
-
Choi AR, D'Agostino RB, Farris MK, Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Ruiz J, Lycan TW, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Li W, Su J, Whitlow C, Xing F, Chan MD. Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Front Endocrinol (Lausanne). 2024; 15:1364021.
Score: 0.046
-
Hassan S, Karpova Y, Flores A, D'Agostino R, Kulik G. Surgical stress delays prostate involution in mice. PLoS One. 2013; 8(11):e78175.
Score: 0.022
-
Blackham AU, Northrup SA, Willingham M, D'Agostino RB, Lyles DS, Stewart JH. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. Surgery. 2013 Mar; 153(3):333-43.
Score: 0.020